Priyaranjan Pattanaik (PP) is a seasoned scientist and business leader with over 23 years of experience in the pharmaceutical and biotech sectors, particularly in the CRO/CDMO space.

With deep expertise in biotherapeutics, including antibodies, bispecifics, ADCs, peptides, proteins, and cell and gene therapies, PP has successfully taken forward programs from early discovery to clinical development. He is also a passionate mentor and champion of talent development and innovation.

He holds a PhD in Structural Biology from JNCASR, Bangalore, and completed his postdoctoral research in structure-based drug discovery at Case Western Reserve University, USA.